• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• About NICE

• Who we are
  • Structure of NICE
  • Board
  • Senior Management Team
  • Guidance Executive
  • Partners Council
  • Policies and procedures
  • About the HDA
    • HDA publications
    • Evidence Base
    • NPHL Thesaurus
• What we do
• How we work
• NICE website development
• Jobs
• Tenders
• Scientific advice
• Commissioning Outcomes Framework
• Quality and Outcomes Framework
• NICE International
• NHS Evidence

Guidance for smokefree hospital trusts

The recent white paper, Choosing health: making healthy choices easier, announced that the NHS will be smokefree by the end of 2006. This guidance document provides the rationale for why the NHS should become smokefree, defines what is meant by smokefree and sets out the steps needed for NHS trusts to become smokefree. It is based on the learning from a survey of hospitals carried out by the HDA at the end of 2003, three detailed case studies and consultations with individuals who have been involved in implementing smokefree policies. The document should be read in conjunction with the HDA briefing paper, The case for a completely smokefree NHS in England. This briefing paper sets out the case for a completely smokefree policy across the NHS and counters objections from those who say it cannot be done.

Guidance for smokefree hospital trusts 26 January 2005 (166.3Kb 01min 58sec @ 28.8Kbps)

Adobe Acrobat reader required.

This page was last updated: 30 April 2009